Catalyst Biosciences (CBIO) PT Lowered to $24.50 at Ladenburg Thalmann
Tweet Send to a Friend
Ladenburg Thalmann lowered its price target on Catalyst Biosciences (NASDAQ: CBIO) to $24.50 (from $47.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
